A Question About Pond Algae Just Won a Nobel Prize
Key points
- The 2026 Nobel Prize in Physiology or Medicine went to Peter Hegemann, Georg Nagel and Karl Deisseroth for light-gated ion channels and optogenetics.
- It began in the early 1990s with one small question: how does a green alga swim toward the light?
- About thirty years later, the same idea gave a blind man in Paris enough sight to find a notebook on a table.
- I talked it through with Phil Whelan on RTHK Radio 3 the next day, along with the man who may have read his own obituary, and why penicillin works less well than it used to. You can listen below.
- For anyone thinking about the future, it shows how far one small signal can ripple, and why it pays to keep room for questions nobody can justify yet.
In the early 1990s, a scientist called Peter Hegemann was working at a Max Planck Institute in Germany. He wanted to know something small. How does a single-celled green alga, the kind that turns pond water green, find its way toward the light?
He wasn’t building a product, and nobody had asked him to fix a problem, so he followed the question because he was curious. Like a lot of great researchers, he ended up living and breathing it for years.
On 5 October in Stockholm, that question shared the Nobel Prize in Physiology or Medicine. Hegemann, Georg Nagel and Karl Deisseroth were named “for their discoveries concerning light-gated ion channels and optogenetics”.
Listen: the Nobel Prizes on RTHK Radio 3
I chat with Phil Whelan on RTHK Radio 3 in Hong Kong each week, and on 6 October we spent most of the segment on the Nobels. Here’s that part of the chat, about 13 minutes.
How pond algae led to the Nobel Prize for optogenetics
The word itself is two words joined together. Opto means light, and genetics means genes, so optogenetics is the use of light to switch on cells that have been given a gene that reacts to it.
Here’s the path, one step at a time.
Hegemann and Nagel found the answer to the alga question. It was a protein, now called channelrhodopsin, that sits in the outer skin of the cell and opens like a gate the moment light hits it.
Then Karl Deisseroth’s lab at Stanford put the gene for that protein into the nerve cells of rats, and in a landmark 2005 paper they showed that a flash of blue light could fire those cells on cue.
That gave scientists a light switch for the brain. They could turn chosen nerve cells on and off and watch what changed, which the chair of the Nobel Committee described to STAT News as “mapping the brain in a way that we could once only dream of”.
Then, in May 2021, a team in Paris led by Jose-Alain Sahel and Botond Roska reported in Nature Medicine on a 58-year-old man who had been blind for close to four decades from an eye disease called retinitis pigmentosa. They injected his eye with genes for a light-sensing protein first found in green algae, and gave him goggles with a camera that turned what was in front of him into amber light.
With the goggles on, he reached out and touched a notebook on the table 92% of the time, according to the Sorbonne University release. Without them, he couldn’t do any of the visual tasks. He could count glass tumblers as well, though what he saw was grainy black and white, not enough to read a page or know a face.
It hasn’t cured blindness yet. What it has done is show that the idea can work in a person, and that’s why it took about thirty years to get from a pond to a patient, and why nobody standing at the pond in the early 1990s could have drawn that line.
The man who may have read his own obituary
The prize carries the name of Alfred Nobel, a Swedish chemist who invented dynamite, held 355 patents and made a fortune.
The story goes like this. In 1888 his brother Ludvig died in France, and a French newspaper thought it was Alfred who had died. It ran his obituary under the line “The merchant of death is dead”. Alfred read it, didn’t like how he’d be remembered, and set about changing it.
It’s a great story, and it might even be true, but nobody has ever found a copy of that newspaper, so I tell it as a story.
What we do know is that on 27 November 1895, in Paris, Nobel signed his last will. He left most of his estate, more than 31 million Swedish kronor, to a fund whose interest would pay for prizes “to those who, during the preceding year, have conferred the greatest benefit to humankind”. The Nobel Foundation puts that fortune at about 2.2 billion kronor in today’s money.
He died on 10 December 1896, and the first prizes were handed out on 10 December 1901, which is why they’re still handed out on that date every year.
And how it all works now:
- His will set up five prizes: physics, chemistry, medicine, literature and peace.
- Physics and chemistry are chosen by the Royal Swedish Academy of Sciences, medicine by the Karolinska Institute and literature by the Swedish Academy, all in Stockholm.
- Peace is chosen by five people picked by Norway’s parliament, so it’s announced in Oslo.
- The economics prize came later, paid for by Sweden’s central bank, and its full name is the Sveriges Riksbank Prize in Economic Sciences in Memory of Alfred Nobel.
- This year each full prize is worth 12 million Swedish kronor.
- The names of everyone nominated stay sealed for 50 years, so we’ll find out in 2076 who nearly won this year.
They don’t all land on one big night, either. This year they’re announced one at a time from 5 to 12 October, with peace from Oslo on 9 October.
If the obituary story is true, it’s a man who got an early look at one possible future, his own, and chose a different one, and I like that, because seeing what might be coming is only useful if you then choose forward.
Nobel Prizes you already carry with you
The optogenetics prize is early. Nobody knows yet what it will turn into. But some older prizes are so much a part of our lives that we don’t see them any more.
- The very first physics prize, in 1901, went to Wilhelm Röntgen for discovering the rays we now call X-rays.
- In 1923, Frederick Banting and John Macleod shared the medicine prize for the discovery of insulin, which changed type 1 diabetes from a death sentence into something people live with.
- In 1945, Alexander Fleming, Ernst Chain and Howard Florey shared it for penicillin.
- In 2003, Paul Lauterbur and Peter Mansfield shared it for magnetic resonance imaging, the MRI scan.
And last year, in 2025, the medicine prize went to Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance”. They found the cells that keep our immune system from attacking our own body. The Nobel committee called them the immune system’s “security guards”, and on air I called them the peacekeepers, the cells that decide what gets through and what doesn’t. It’s another one that might take decades to reach the clinic.
None of these arrived finished. Each one was a piece of proven research, checked hard before the prize, and the prize brought it attention and made the next round of funding much easier to find.
When penicillin became ordinary
Penicillin came out of mould, and the optogenetics story came out of pond scum. Phil pointed out on air that a lot of great discoveries come out of goo, and he’s right.
Penicillin worked so well that it became ordinary. A shot of it for a bad infection is something most of us now take for granted, and that’s where the next ripple came from.
On air I said our bodies have built up a kind of immunity to it, but it’s actually the bacteria that change. When they meet penicillin in doses too small to kill them, the ones that survive can learn to resist it, so for some people it no longer works the way it once did.
Fleming saw it coming. In his Nobel lecture in December 1945 he warned that taking too little could make microbes resistant, and put it plainly: “If you use penicillin, use enough.”
That’s a ripple of its own. The thing that made penicillin so useful, how easy and ordinary it became, is the same thing that wore it down. I wrote about that pattern in January, after another chat with Phil, about the unintended consequences of new technology and how rarely anyone knows what they’re starting.
On air with Phil
Phil asked whether this would end in new drugs. My answer was that nobody knows yet, but it could go well beyond drugs, because the trick is putting a light-sensing switch into cells that need light, and the eye is the obvious first place.
Phil also called it “a grower, not a shower”, which is about right. Low-resolution sight in one man sounds small, and if someone showed you only that, you might ask why anyone would bother.
The answer is that the knowing matters, and so does what other people make of it. The person who first works out an idea is often not the person who finds its best use, and Phil put it neatly when he said it’s the neighbour. Somewhere right now, someone is reading about this and thinking it fits the thing they’ve been working on, and that’s where the next ripple could come from.
The alga was a small signal nobody could read for thirty years
This is close to a perfect picture of what foresight is for.
A small signal is the odd thing you notice before it means anything. In May 2024 I wrote that foresight means looking for “emerging trends, weak signals, and potential disruptions before they become mainstream“. A green alga turning toward the sun is about as weak as a signal gets. It sat in every pond on earth, in plain sight, and for most of those thirty years it looked like it meant nothing much at all to anyone outside a lab.
That’s the hard part of signals, because the one that matters rarely looks like it matters on the day you see it.
One small question can ripple a long way
In April 2026 I wrote about Ripple Effects, and put it like this: “A small change in one space… creates a much larger shift somewhere else.” And then: “The original signal doesn’t stay contained. It moves.”
Watch it move here.
The first ripple was a protein that opens to light, in plant biology. The second was a light switch for nerve cells in rats, in brain science. The third was a man in Paris finding a notebook, in eye medicine, a field the pond question never had in mind, and each ripple reached somewhere the one before it couldn’t see.
Where the fourth and fifth go is anyone’s guess, and that matters, because your business is full of small questions that could travel just as far.
Foresight is preparation for many futures
No forecast in the early 1990s had a blind patient at the end of it, and none could have.
So the job is to get ready for several futures at once, instead of betting everything on the one you think is most likely. In January 2026 I wrote that foresight works best as “preparation for the conditions under which decisions are made“, and that done well, it “builds the habit of asking better questions before urgency takes over.”
Futures, plural, is the point. In October 2025, writing about solar roofs on cars, I called one section Many Energies, Many Futures, and said that when we’re curious about new kinds of energy, we find ways to make them work, but “If we’re defensive, we find reasons they can’t.“
The pond question could have led nowhere, and a defensive budget would have said so early. It could have led to a lab tool and stopped there. It led to a Nobel Prize and a man touching a notebook, and if you want to be ready for an outcome like that, keep more than one door open for longer than feels comfortable.
Why the odd question rarely gets an hour
In March 2025 I wrote that the best research isn’t about finding one answer, it’s about asking better questions. In the same piece I said that “every strategist, every business leader, every decision-maker is a researcher.”
The alga question was asked long before anyone had a question about the brain, or about blindness, to hang it on.
Most budgets want to see a payoff by next June. When money’s tight that makes sense, because you can’t pay wages with a maybe. But it means the odd question, the one nobody can justify yet, never gets an owner, a name beside it or even a spare hour.
A business that only funds what it can already explain might end up very good at last year’s problems. The people closest to the work often notice the strange thing first, like the customer who keeps asking for something you don’t sell, or the part that wears out in a way it shouldn’t, and that’s usually where they stop, because there’s no line in the plan for it.
My position is plain. A small, steady amount of time for curiosity is worth protecting, even when you can’t say what it’s for, because nobody can know in advance which question will end up mattering.
One question, one name, one hour
Start with one question nobody in your business is paid to ask.
Write it down.
Put a person’s name next to it.
Give it an hour a month, and leave it alone for a year before you judge it.
At the end of that year, sit down and ask what they found. It might be nothing much, or it might be the first step of something that takes thirty years to reach the people it’s for.
And while you’re at it, think back. What were you curious about years ago that turned out to matter?
Questions people ask
What did the 2026 Nobel Prize in Medicine go to?
It went to Peter Hegemann, Georg Nagel and Karl Deisseroth for their discoveries about light-gated ion channels and optogenetics. Their work lets scientists switch chosen brain cells on and off with light, so they can see what each cell does.
What is optogenetics, in simple words?
Optogenetics puts a light-sensitive protein, first found in green algae, into chosen cells. When light shines on those cells, they switch on. Scientists use it to study the brain, and a team in Paris used a version of it to give a blind man partial sight in 2021.
Why is it called the Nobel Prize?
It’s named after Alfred Nobel, the Swedish chemist who invented dynamite. In his last will, signed in Paris in 1895, he left most of his fortune, more than 31 million Swedish kronor, to fund the prizes. The first ones were handed out in 1901.
How much is a Nobel Prize worth in 2026?
Each full prize in 2026 is worth 12 million Swedish kronor. When a prize is shared, the winners split it.
What does the optogenetics Nobel Prize teach us about foresight?
It shows that a small, odd question can ripple into fields nobody had in mind, in this case thirty years later. Foresight means noticing small signals early, getting ready for more than one possible future, and giving curious questions time before anyone can say what they’re for.
Sources
- Nobel Prize press release, 5 October 2026.
- STAT News, 5 October 2026: 2026 Nobel Prize in Medicine awarded for brain research tool called optogenetics.
- Sorbonne University, 24 May 2021: Optogenetic Methods Restore Partial Vision in a Blind Patient.
- Sahel, Roska et al., Nature Medicine, 24 May 2021: Partial recovery of visual function in a blind patient after optogenetic therapy.
- Ophthalmology Times, May 2021, and STAT News, 24 May 2021, on the same study.
- The Nobel Prize website: Alfred Nobel’s will, Alfred Nobel’s life, the prize money, the 2026 announcements and the nomination archive.
- The Nobel Prize website: Physiology or Medicine 2025 press release, 6 October 2025.
- Alexander Fleming, Nobel lecture: Penicillin, December 1945.
- RTHK Radio 3, The Brew with Phil Whelan, 6 October 2026.
Choose forward.
If you’d like a short read every Tuesday on what’s coming and what it means for your work: <a href=”https://welcome.morrismisel.com/join” target=”_blank” rel=”noopener”>welcome.morrismisel.com/join</a>